Determination of nabumetone and its major metabolite in plasma and tablet formulations by reverse-phase HPLC

Analytical Letters

Volumn 30, Issue 14, 1997, Pages 2485-2492

  Al Momani, Idrees F ^a  

^a YARMOUK UNIVERSITY   (Jordan)

Author keywords

Analysis; HPLC; Nabumetone; Reverse phase; Stability

Indexed keywords

EID: 0030819191     PISSN: 00032719     EISSN: None     Source Type: Journal    
DOI: 10.1080/00032719708001759     Document Type: Article

References (4)

1. A.F. Heather and A.T. Peter, Drugs, 35, 504-524 (1988).
2. F.G. McMahon, R. Vargas, J.R. Ryan and D.A. Fitts, The American Journal of Medicine, 83 (Suppl. 4B), 92-95 (1987).
3. LE. Ray and R.O. Day, J. of Chromatography, 336, 234-238, (1984).
4. J.R. Boelaert H.A. Jonnaert, R.F. Daneels, M.L. Schurers, A.R. Thamely, N.A. Undre and D.L. Cooper, The American Journal of Medicine, 83 (Suppl. 4B), 107-109 (1987).